Advertisement
UK markets closed
  • FTSE 100

    8,213.49
    +41.34 (+0.51%)
     
  • FTSE 250

    20,164.54
    +112.21 (+0.56%)
     
  • AIM

    771.53
    +3.42 (+0.45%)
     
  • GBP/EUR

    1.1653
    -0.0030 (-0.25%)
     
  • GBP/USD

    1.2548
    +0.0014 (+0.12%)
     
  • Bitcoin GBP

    49,297.06
    +2,226.36 (+4.73%)
     
  • CMC Crypto 200

    1,339.85
    +62.87 (+4.92%)
     
  • S&P 500

    5,127.97
    +63.77 (+1.26%)
     
  • DOW

    38,697.52
    +471.86 (+1.23%)
     
  • CRUDE OIL

    78.44
    -0.51 (-0.65%)
     
  • GOLD FUTURES

    2,308.70
    -0.90 (-0.04%)
     
  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     
  • HANG SENG

    18,475.92
    +268.79 (+1.48%)
     
  • DAX

    18,001.60
    +105.10 (+0.59%)
     
  • CAC 40

    7,957.57
    +42.92 (+0.54%)
     

A Look At The Fair Value Of Transense Technologies plc (LON:TRT)

Key Insights

  • Transense Technologies' estimated fair value is UK£1.02 based on 2 Stage Free Cash Flow to Equity

  • With UK£1.04 share price, Transense Technologies appears to be trading close to its estimated fair value

  • The average discount for Transense Technologies' competitorsis currently 7.4%

Does the October share price for Transense Technologies plc (LON:TRT) reflect what it's really worth? Today, we will estimate the stock's intrinsic value by estimating the company's future cash flows and discounting them to their present value. One way to achieve this is by employing the Discounted Cash Flow (DCF) model. It may sound complicated, but actually it is quite simple!

We generally believe that a company's value is the present value of all of the cash it will generate in the future. However, a DCF is just one valuation metric among many, and it is not without flaws. If you still have some burning questions about this type of valuation, take a look at the Simply Wall St analysis model.

ADVERTISEMENT

Check out our latest analysis for Transense Technologies

Is Transense Technologies Fairly Valued?

We are going to use a two-stage DCF model, which, as the name states, takes into account two stages of growth. The first stage is generally a higher growth period which levels off heading towards the terminal value, captured in the second 'steady growth' period. In the first stage we need to estimate the cash flows to the business over the next ten years. Seeing as no analyst estimates of free cash flow are available to us, we have extrapolate the previous free cash flow (FCF) from the company's last reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years.

A DCF is all about the idea that a dollar in the future is less valuable than a dollar today, so we discount the value of these future cash flows to their estimated value in today's dollars:

10-year free cash flow (FCF) estimate

2024

2025

2026

2027

2028

2029

2030

2031

2032

2033

Levered FCF (£, Millions)

UK£632.9k

UK£789.5k

UK£929.5k

UK£1.05m

UK£1.15m

UK£1.23m

UK£1.29m

UK£1.35m

UK£1.39m

UK£1.43m

Growth Rate Estimate Source

Est @ 34.76%

Est @ 24.75%

Est @ 17.74%

Est @ 12.83%

Est @ 9.39%

Est @ 6.99%

Est @ 5.31%

Est @ 4.13%

Est @ 3.30%

Est @ 2.73%

Present Value (£, Millions) Discounted @ 8.5%

UK£0.6

UK£0.7

UK£0.7

UK£0.8

UK£0.8

UK£0.8

UK£0.7

UK£0.7

UK£0.7

UK£0.6

("Est" = FCF growth rate estimated by Simply Wall St)
Present Value of 10-year Cash Flow (PVCF) = UK£7.0m

The second stage is also known as Terminal Value, this is the business's cash flow after the first stage. The Gordon Growth formula is used to calculate Terminal Value at a future annual growth rate equal to the 5-year average of the 10-year government bond yield of 1.4%. We discount the terminal cash flows to today's value at a cost of equity of 8.5%.

Terminal Value (TV)= FCF2033 × (1 + g) ÷ (r – g) = UK£1.4m× (1 + 1.4%) ÷ (8.5%– 1.4%) = UK£20m

Present Value of Terminal Value (PVTV)= TV / (1 + r)10= UK£20m÷ ( 1 + 8.5%)10= UK£8.9m

The total value is the sum of cash flows for the next ten years plus the discounted terminal value, which results in the Total Equity Value, which in this case is UK£16m. The last step is to then divide the equity value by the number of shares outstanding. Compared to the current share price of UK£1.0, the company appears around fair value at the time of writing. Valuations are imprecise instruments though, rather like a telescope - move a few degrees and end up in a different galaxy. Do keep this in mind.

dcf
dcf

The Assumptions

Now the most important inputs to a discounted cash flow are the discount rate, and of course, the actual cash flows. You don't have to agree with these inputs, I recommend redoing the calculations yourself and playing with them. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Transense Technologies as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 8.5%, which is based on a levered beta of 1.211. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.

SWOT Analysis for Transense Technologies

Strength

  • Earnings growth over the past year exceeded the industry.

  • Currently debt free.

Weakness

  • Earnings growth over the past year is below its 5-year average.

Opportunity

  • Annual earnings are forecast to grow faster than the British market.

  • Good value based on P/E ratio compared to estimated Fair P/E ratio.

Threat

  • No apparent threats visible for TRT.

Next Steps:

Although the valuation of a company is important, it is only one of many factors that you need to assess for a company. DCF models are not the be-all and end-all of investment valuation. Instead the best use for a DCF model is to test certain assumptions and theories to see if they would lead to the company being undervalued or overvalued. For instance, if the terminal value growth rate is adjusted slightly, it can dramatically alter the overall result. For Transense Technologies, there are three relevant factors you should assess:

  1. Risks: To that end, you should learn about the 3 warning signs we've spotted with Transense Technologies (including 1 which can't be ignored) .

  2. Management:Have insiders been ramping up their shares to take advantage of the market's sentiment for TRT's future outlook? Check out our management and board analysis with insights on CEO compensation and governance factors.

  3. Other High Quality Alternatives: Do you like a good all-rounder? Explore our interactive list of high quality stocks to get an idea of what else is out there you may be missing!

PS. The Simply Wall St app conducts a discounted cash flow valuation for every stock on the AIM every day. If you want to find the calculation for other stocks just search here.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.